FDA Status Most peptides used therapeutically are obtained through FDA-registered compounding pharmacies
Higher retatrutide doses (10-12 mg) produce more GI side effects and carry a higher risk of dysesthesia (tingling/numbness) without engaging the amylin pathway
Simultaneously, some cells undergo cell cycle arrest and become senescent owing to the inhibition of cyclin-dependent kinases mediated by p21 activation through the DDR pathway 11
No evidence of serious hormonal, hepatic, or systemic adverse effects has been observed in available data
Unlike natural GHRH, CJC-1295 is modified with Drug Affinity Complex (DAC) technology, which significantly extends its half-life allowing for sustained GH release over the course of a week with fewer injections
Furthermore, our clinic provides Lipotropic injections that can accelerate the metabolism of fat, and Vitamin D injections aimed at improving bone health and immune function